Showing results (301-310 of 312) with videos related to

Sort By:
Pageof 32
Cell Death and Differentiation|May 19, 2007
Apoptosis-based dual molecular targeting by INNO-406, a second-generation Bcr-Abl inhibitor, and ABT-737, an inhibitor of antiapoptotic Bcl-2 proteins, against Bcr-Abl-positive leukemiaJ Kuroda, S Kimura, A Strasser, et al.
Frontiers in Genetics|December 13, 2023
Personalized medicine in a community health system: the NorthShore experienceSean P David, Henry M Dunnenberger, Sarah Choi, et al.
Clinical and Translational Science|January 20, 2018
Implementation of Standardized Clinical Processes for TPMT Testing in a Diverse Multidisciplinary Population: Challenges and Lessons LearnedKristin W Weitzel, D Max Smith, Amanda R Elsey, et al.
Cell Death and Differentiation|February 9, 2010
Glyoxalase-I is a novel target against Bcr-Abl+ leukemic cells acquiring stem-like characteristics in a hypoxic environmentM Takeuchi, S Kimura, J Kuroda, et al.
Bone Marrow Transplantation|March 2, 2011
Secondary solid tumors after allogeneic hematopoietic SCT in JapanA Yokota, S Ozawa, T Masanori, et al.
Blood Cancer Journal|July 26, 2012
AV-65, a novel Wnt/β-catenin signal inhibitor, successfully suppresses progression of multiple myeloma in a mouse modelH Yao, E Ashihara, J W Strovel, et al.
Bone Marrow Transplantation|October 6, 2015
A randomized controlled trial of cyclosporine and tacrolimus with strict control of blood concentrations after unrelated bone marrow transplantationY Kanda, T Kobayashi, T Mori, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 24, 2019
CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trialD Max Smith, Kristin W Weitzel, Amanda R Elsey, et al.
Bone Marrow Transplantation|November 24, 2015
Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomesK Yakushijin, Y Atsuta, N Doki, et al.
Blood Cancer Journal|July 26, 2012
Prognostic factors influencing clinical outcome of allogeneic hematopoietic stem cell transplantation following imatinib-based therapy in BCR-ABL-positive ALLS Mizuta, K Matsuo, T Maeda, et al.
Pageof 32